Aspen Neuroscience’s stem cell therapy improved Parkinson’s disease symptoms for all eight treated patients after one year, with the San Diego biotech now planning for a pivotal phase 3 trial later ...
CLEVELAND — A groundbreaking randomized clinical trial led by Chair of Radiation Oncology Daniel Spratt at University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results